CTN Dissemination Library

  • Browse & Search
    • Search the CTN Library
    • In press articles
    • Search the site/blog
  • Nodes
  • Protocols
  • Training
    • CTN & Other Training
    • Upcoming Events
  • Resources
    • What’s New Blog
    • NIDA CTN Site
    • CTN Bulletin
    • CTN Common Data Elements (CDE)
    • CTN Directory (2025)
    • PATHS Toolkit
    • Implementation
    • General Resources
  • About Us
  • Browse & Search
    • Search the CTN Library
    • In press articles
    • Search the site/blog
  • Nodes
  • Protocols
  • Training
    • CTN & Other Training
    • Upcoming Events
  • Resources
    • What’s New Blog
    • NIDA CTN Site
    • CTN Bulletin
    • CTN Common Data Elements (CDE)
    • CTN Directory (2025)
    • PATHS Toolkit
    • Implementation
    • General Resources
  • About Us
  • Racial and ethnic differences in treatment outcomes among adults with stimulant use disorders after a dosed exercise intervention.

    Sanchez K, Greer TL, Walker NR, Carmody T, Rethorst CD, Trivedi MH. Racial and ethnic differences in treatment outcomes among adults with stimulant use disorders after a dosed exercise intervention. Journal of Ethnicity in Substance Abuse 2017;16(4):495-510.

    Read More
  • Family discord after completion of an outpatient community treatment program predicts greater substance use during follow-up.

    Nakonezny PA, Denton WH, Westover AN, Adinoff BH. Family discord after completion of an outpatient community treatment program predicts greater substance use during follow-up. Substance Use & Misuse 2017;52(12):1624-1633.

    Read More
  • A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

    Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug and Alcohol Dependence 2017;177:249-257.

    Read More
  • Prescription opioid registry protocol in an integrated health system.

    Ray GT, Bahorik AL, VanVeldhuisen PC, Weisner CM, Rubinstein AL, Campbell CI. Prescription opioid registry protocol in an integrated health system. American Journal of Managed Care 2017;23(5):e146-e155.

    Read More
  • Frequency of cannabis use among primary care patients in Washington State.

    Lapham GT, Lee AK, Caldeiro RM, McCarty D, Browne KC, Walker DD, Kivlahan DR, Bradley KA. Frequency of cannabis use among primary care patients in Washington State. Journal of the American Board of Family Medicine 2017;30(6):795-805.

    Read More
  • Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: A Secondary post hoc analysis of the Project HOPE study.

    Stitzer ML, Matheson T, Cunningham C, Sorensen JL, Feaster DJ, Gooden LK, Hammond AX, Fitzsimons H, Metsch LR. Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: A Secondary post hoc analysis of the Project HOPE study. Addiction Science & Clinical Practice 2017;12:16.

    Read More
  • Demographic and clinical characteristics of treatment seeking women with full and subthreshold PTSD and concurrent cannabis and cocaine use disorders.

    Ruglass LM, Shevorykin A, Brezing C, Hu M, Hien DA. Demographic and clinical characteristics of treatment seeking women with full and subthreshold PTSD and concurrent cannabis and cocaine use disorders. Journal of Substance Abuse Treatment 2017;80:45-51.

    Read More
  • DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.

    Wu L, McNeely J, Subramaniam GA, Brady KT, Sharma G, VanVeldhuisen PC, Zhu H, Schwartz RP. DSM-5 substance use disorders among adult primary care patients: Results from a multisite study. Drug and Alcohol Dependence 2017;179:42-46.

    Read More
  • Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life.

    Hser Y, Mooney LJ, Huang D, Zhu Y, Tomko RL, McClure E, Chou C, Gray KM. Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. Journal of Substance Abuse Treatment 2017;81:53-58.

    Read More
  • Smoking-related outcomes and associations with tobacco-free policy in addiction treatment, 2015-2016.

    Guydish JR, Yip D, Le T, Gubner N, Delucchi KL, Roman PM. Smoking-related outcomes and associations with tobacco-free policy in addiction treatment, 2015-2016. Drug and Alcohol Dependence 2017;179:355-361.

    Read More
4142434445

Recent Posts

  • Now in the CTN Library: NIDA CTN Common Data Elements
  • New in the Library (March – April 2026)
  • CTN Primary Care SIG Webinar: Conducting Substance Use Research in Prison (March 23, 2026, 12pm ET)
  • New in the Library (February – March 2026)
  • News from the Appalachian Node: Brief Report for CTN-0135 Published

Recent Comments

No comments to show.

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • September 2022

Categories

  • DSC News
  • Events
  • Funding
  • Jobs
  • New in the Library
  • Node News
  • Other
  • Protocol News
  • SIG Updates
  • Uncategorized
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Department of Psychiatry & Behavioral Science's Addictions, Drug & Alcohol Institute (ADAI). The materials on this site have neither been created nor reviewed by NIDA.